Oryzon Genomics SA
MAD:ORY
Oryzon Genomics SA
MAD:ORY
Price:
2.812
EUR
Market Closed
Market Cap:
€224.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Oryzon Genomics SA
MAD:ORY
|
ES |
|
B
|
BBI Development SA
WSE:BBD
|
PL |
|
M
|
MetLife Inc
F:MWZ
|
US |
|
W
|
Wintest Corp
TSE:6721
|
JP |
|
E
|
Enagas SA
XMUN:EG4
|
ES |
|
Croma Security Solutions Group PLC
LSE:CSSG
|
UK |
|
M
|
MetLife Inc
XMUN:MWZ
|
US |
|
D
|
DBS Group Holdings Ltd
XBER:DEVL
|
SG |
|
P
|
Principal Financial Group Inc
XMUN:PG4
|
US |
|
E
|
Estrima SpA
MIL:BIRO
|
IT |
Wall St Price Targets
ORY Price Targets Summary
Oryzon Genomics SA
Oryzon Genomics SA
Wall Street analysts forecast ORY stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ORY is 7.854 EUR with a low forecast of 4.242 EUR and a high forecast of 12.6 EUR.
Lowest Forecast
Price Target
4.242
EUR
51% Upside
Average Forecast
Price Target
7.854
EUR
179% Upside
Highest Forecast
Price Target
12.6
EUR
348% Upside
Oryzon Genomics SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ORY's stock price target?
Price Target
7.854
EUR
7.854
EUR
According to Wall Street analysts, the average 1-year price target for ORY is 7.854 EUR with a low forecast of 4.242 EUR and a high forecast of 12.6 EUR.
